UPDATE 1-Valeant reports better-than-expected profit, raises forecast
October 20, 2014 at 08:10 AM EDT
Oct 20 (Reuters) - Canada's Valeant Pharmaceuticals International Inc , embroiled in a bitter fight to take over Botox maker Allergan Inc, posted a better-than-expected quarterly profit, driven by demand for its skin, neuro and eye drugs.
